Pilot study of combined therapy with ω-3 fatty acids and niacin in atherogenic dyslipidemia

Journal of Clinical Lipidology

Volumn 1, Issue 3, 2007, Pages 211-217

  Isley, William L ^a   Miles, John M ^a   Harris, William S ^b  

^a MAYO CLINIC   (United States)

^b UNIVERSITY OF MISSOURI KANSAS CITY SCHOOL OF MEDICINE   (United States)

Author keywords

Fish oils; Flushing reaction; HDL cholesterol; LDL subfractions; LDL cholesterol; Lipoproteins; Nicotinic acid; Triglyceride

Indexed keywords

CHOLESTEROL; DOCOSAHEXAENOIC ACID; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; ICOSAPENTAENOIC ACID; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; NICOTINIC ACID; OMEGA 3 FATTY ACID; PLACEBO; TRIACYLGLYCEROL;

ADULT; AGED; ANALYSIS OF VARIANCE; ARTICLE; ATHEROGENESIS; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET RESTRICTION; DRUG DOSE ESCALATION; DYSLIPIDEMIA; FEMALE; FLUSHING; HUMAN; MALE; MONOTHERAPY; PARALLEL DESIGN; PATIENT COMPLIANCE; PILOT STUDY; PRIORITY JOURNAL; SIDE EFFECT; STATISTICAL SIGNIFICANCE; TREATMENT DURATION; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 34447297296     PISSN: 19332874     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacl.2007.05.002     Document Type: Article

References (53)

1. Johnson L.W., and Weinstock R.S. The metabolic syndrome: concepts and controversy. Mayo Clin Proc 81 (2006) 1615-1620
2. Laakso M. Insulin resistance and coronary heart disease. Curr Opin Lipidol 7 (1996) 217-226
3. Harris W.S. n-3 Fatty acids and serum lipoproteins: human studies. Am J Clin Nutr 65 suppl (1997) 1645S-1654S
4. Aleswad K., Pogson G.W., Harris W.S., Sherwani K., and Bell H.H. Effects of phenytoin, niacin, gemfibrozil and omega-3 fatty acids on HDL in patients with hypoalphalipoproteinemia. Prev Cardiol 2 (1999) 144-150
5. Henkin Y., Oberman A., Hurst D.C., and Segrest J.P. Niacin revisited: clinical observations on an important but underutilized drug. Am J Med 91 (1991) 239-246
6. Kenny D., and Egan B.M. Is there a role for dietary fish oil in the treatment of hypertension?. J Hum Hypertens 8 (1994) 895-905
7. Sacks F.M., Hebert P., Appel L.J., et al. Trials of Hypertension Prevention Collaborative Research Group. Short report: the effect of fish oil on blood pressure and high-density lipoprotein-cholesterol levels in phase 1 of the Trials of Hypertension Prevention. J Hypertens 12 (1994) S23-S31
8. Grundy S.M., Mok H.Y.I., Zech L., and Berman M. Influence of nicotinic acid on metabolism of cholesterol and triglycerides in man. J Lipid Res 22 (1981) 24-36
9. McKenney J., Proctor J.D., Harris S., and Chinchilli V.M. A comparison of the efficacy and toxic effects of sustained- vs immediate-release niacin in hypercholesterolemic patients. JAMA 271 (1994) 672-677
10. Harris W.S. Fish oils and plasma lipid and lipoprotein metabolism in humans: a critical review. J Lipid Res 30 (1989) 785-807
11. Harris W.S., Ginsberg H.N., Arunakul N., et al. Safety and efficacy of Omacor in severe hypertriglyceridemia. J Cardiovasc Risk 4 (1997) 385-392
12. Capuzzi D.M., Morgan J.M., Brusco O.A., and Intenzo C.M. Niacin dosing: relationship to benefits and adverse effects. Curr Atheroscler Rep 2 (2000) 64-71
13. Dyerberg J., and Jorgensen K.A. Marine oils and thrombogenesis. Prog Lipid Res 21 (1982) 255-269
14. Knapp H.R. Dietary fatty acids in human thrombosis and hemostasis. Am J Clin Nutr 65 suppl (1997) 1687S-1698S
15. Summary of the second report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel II). JAMA 269 (1993) 3015-3023
16. Denke M.A., Fox M.M., and Schulte M.C. Short-term dietary calcium fortification increases fecal saturated fat content and reduces serum lipids in men. J Nutr 6 (1993) 1047-1053
17. Bell L., Halstenson C.E., Halstenson C., Macres M., and Keane W.F. Cholesterol-lowering effects of calcium carbonate in patients with mild to moderate hypercholesterolemia. Arch Intern Med 152 (1992) 2441-2444
18. Warnick G.R., and Albers J.J. A comprehensive evaluation of the heparin-manganese precipitation procedure for estimating high density lipoprotein cholesterol. J Lipid Res 19 (1978) 65-76
19. Harris W.S., Windsor S.L., and Caspermeyer J.J. Modification of lipid-related atherosclerosis risk factors by ω3 fatty acid ethyl esters in hypertriglyceridemic patients. J Nutr Biochem 4 (1993) 706-712
20. Ziogas G., Thomas T.R., and Harris W.S. Exercise training, postprandial hypertriglyceridemia, and LDL subfraction distribution. Med Sci Sports Exerc 29 (1997) 986-991
21. Seman L.J., Jenner J.L., McNamara J.R., and Schaefer E.J. Quanitification of lipoprotein(a) in plasma by assaying cholesterol in lectin-bound plasma fraction. Clin Chem 40 (1994) 400-403
22. Harris W.S., and Muzio F. Fish oil reduces postprandial triglyceride concentrations without accelerating lipid emulsion removal rates. Am J Clin Nutr 58 (1993) 68-74
23. Montori V.M., Farmer A., Wollan P.C., and Dinneen S.F. Fish oil supplementation in type 2 diabetes: a quantitative systematic review. Diabetes Care 23 (2000) 1407-1415
24. Harris W.S., Lu G., Rambjor G.S., et al. Influence of n-3 fatty acid supplementation on the endogenous activities of plasma lipases. Am J Clin Nutr 66 (1997) 254-260
25. Elam M.B., Hunninghake D.B., Davis K.B., et al. Effect of niacin on lipid and lipoprotein levels and glycemic control in patients with diabetes and peripheral arterial disease. the ADMIT study: a randomized trial. JAMA 284 (2000) 1263-1270
26. Carlson L.A., and Oro L. The effect of nicotinic acid on the plasma free fatty acids: demonstration of a metabolic type of sympathicolysis. Acta Med Scand 172 (1962) 641-645
27. Lewis G.F. Fatty acid regulation of very low density lipoprotein production. Curr Opin Lipidol 8 (1997) 146-153
28. Gordon T., Castelli W.P., Hjortland M.C., Kannel W.B., and Dawbert T.R. High density lipoprotein as a protective factor against coronary heart disease. Am J Med 62 (1977) 707-714
29. Blum C.B., Levy R.I., Eisenberg S., Hall M., Goebel R.H., and Berman M. High density lipoprotein metabolism in man. J Clin Invest 60 (1977) 795-807
30. Arai T., Yamashita S., Hirano K.I., et al. Increased plasma cholesteryl ester transfer protein in obese subjects: a possible mechanism for the reduction of serum HDL cholesterol levels in obesity. Arterioscler Thromb 14 (1994) 1129-1136
31. Tall A.R. Plasma cholesteryl ester transfer protein. J Lipid Res 34 (1993) 1255-1274
32. Langer T., and Levy R.I. Effects of nicotinic acid on beta-lipoprotein metabolism. Clin Res 18 (1970) 458
33. Huff M.W., and Telford D.E. Dietary fish oil increases conversion of very low density lipoprotein apoprotein B to low density lipoprotein. Arteriosclerosis 9 (1989) 58-66
34. Fisher W.R., Zech L.A., and Stacpoole P.W. Apolipoprotein B metabolism in hypertriglyceridemic diabetic patients administered either a fish oil- or vegetable oil-enriched diet. J Lipid Res 39 (1998) 388-401
35. Tripodi A., Loria P., Dilengite M.A., and Carulli N. Effect of fish oil and coconut oil diet on the LDL receptor activity of rat liver plasma membranes. Biochim Biophys Acta 1083 (1991) 298-304
36. Surrette M.E., Whelan J., Lu G., Broughton K.S., and Kinsella J.E. Dependence on dietary cholesterol for n-3 polyunsaturated fatty acid-induced changes in plasma cholesterol in the Syrian hamster. J Lipid Res 33 (1992) 263-271
37. Lindsey S., Pronczuk A., and Hayes K.C. Low density lipoprotein from humans supplemented with n-3 fatty acids depresses both LDL receptor activity and LDLr mRNA abundance in HepG2 cells. J Lipid Res 33 (1992) 647-658
38. Kaijser L., Eklund B., Olsson A.G., and Carlson L.A. Dissociation of the effects of nicotinic acid on vasodilation and lipolysis by a prostaglandin synthesis inhibitor, indomethacin, in man. Med Biol 57 (1979) 114-117
39. Wilkin J.K., Wilkin O., Kapp R., Donachie R., Chernosky M.E., and Buckner J. Aspirin blocks nicotinic acid-induced flushing. Clin Pharmacol Ther 31 (1982) 478-482
40. Morrow J.D., Parsons III W.G., and Roberts II I.J. Release of markedly increased quantities of prostaglandin D2 in vivo in humans following the administration of nicotinic acid. Prostaglandins 38 (1989) 263-274
41. Li B., Birdwell C., and Whelan J. Antithetic relationship of dietary arachidonic acid and eicosapentaenoic acid on eicosanoid production in vivo. J Lipid Res 35 (1994) 1869-1877
42. Weber P.C. The modification of the arachidonic acid cascade by n-3 fatty acids. Adv Prostaglandin Thromboxane Leukot Res 20 (1990) 232-240
43. Hemker D.P., and Aiken J.W. Effects of prostaglandin D3 on nerve transmission in nictitating membrane of cats. Eur J Pharmacol 67 (1980) 155-158
44. Wendling M.G., and DuCharme D.W. Cardiovascular effects of prostaglandin D3 and D2 in anesthetized dogs. Prostaglandins 22 (1981) 235-243
45. Kulkarni P.S., and Srinivasan B.D. Prostaglandins E3 and D3 lower intraocular pressure. Invest Ophthalmol Vis Sci 26 (1985) 1178-1182
46. Blankenhorn D.H., Nessim S.A., Johnson R.L., Sanmarco M.E., Azen S.P., and Cashin-Hemphill L. Beneficial effects of combined colestipol-niacin therapy on coronary atherosclerosis and coronary venous bypass grafts. JAMA 257 (1987) 3233-3240
47. Brown G., Albers J.J., Fisher L.D., et al. Regression of coronary artery disease as a result of intensive lipid-lowering therapy in men with high levels of apolipoprotein B. N Engl J Med 323 (1990) 1289-1298
48. Keenan J.M., Wenz J.B., Ripsin C.M., Huang Z., and McCaffrey D.J. A clinical trial of oat bran and niacin in the treatment of hyperlipidemia. J Fam Pract 34 (1992) 313-319
49. Nordoy A., Bonaa K.H., Sandset P.M., Hansen J.B., and Nilsen H. Effect of omega-3 fatty acids and simvastatin on hemostatic risk factors and postprandial hyperlipidemia in patients with combinded hyperlipidemia. Arterioscler Thromb Vasc Biol 20 (2000) 259-265
50. Contacos C., Barter P.J., and Sullivan D.R. Effect of pravastatin and ω-3 fatty acids on plasma lipids and lipoproteins in patients with combined hyperlipidemia. Arterioscler Thromb 13 (1993) 1755-1762
51. Roach P.D., Dowling K., Balasubramaniam S., et al. Fish oil and oat bran in combination effectively lower plasma cholesterol in rat. Atherosclerosis 96 (1992) 219-226
52. GISSI-Prevenzione Investigators. Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E in 11,324 patients with myocardial infarction: results of the GISSI-Prevenzione trial. Lancet 354 (1999) 447-455
53. Canner P.L., Berge K.G., Wenger N.K., Stamler J., and Friedman L. Fifteen-year mortality in Coronary Drug Project patients: Long-term benefit with niacin. J Am Coll Cardiol 8 (1986) 1245-1255